SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis
Clin. transl. oncol. (Print)
; 24(2)febrero 2022.
Article
in English
| IBECS
| ID: ibc-203428
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
The use of stereotactic body radiation therapy (SBRT) to treat non-spine bone metastases (NSBM) is becoming increasingly common in clinical practice. The clinical advantages of SBRT include good pain control and high local control rates, although only limited data are available. The Spanish Society of Radiation Oncology (SEOR) SBRT group recently convened a task force of experts in the field to address key questions related to SBRT for NSBM, including treatment indications, planning, techniques, and dose fractionation. The task force reviewed the available literature to develop evidence-based recommendations for the safe application of NSBM SBRT and to standardize and optimize SBRT processes. The present document provides a comprehensive analysis of the available data, including ongoing clinical trials and controversies, providing clinically applicable recommendations.
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Radiotherapy
/
Bone Neoplasms
/
Health Sciences
/
Neoplasm Metastasis
Limits:
Humans
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2022
Document type:
Article
Institution/Affiliation country:
Hospital Duran i Reynals/Spain
/
Hospital General Universitario Gregorio Marañon/Spain
/
Hospital La Luz/Spain
/
Hospital Ruber Internacional Madrid/Spain
/
Hospital Universitario Cruces/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
Hospital Universitario y Politécnico La Fe/Spain